- Home
- CVAC vs DCOM Comparison
CVAC vs DCOM Comparison
Compare CVAC & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- DCOM
- Stock Information
- Founded
- CVAC 2000
- DCOM 1864
- Country
- CVAC Germany
- DCOM United States
- Employees
- CVAC N/A
- DCOM N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- DCOM Major Banks
- Sector
- CVAC Health Care
- DCOM Finance
- Exchange
- CVAC Nasdaq
- DCOM Nasdaq
- Market Cap
- CVAC 1.2B
- DCOM 1.2B
- IPO Year
- CVAC 2020
- DCOM 1996
- Fundamental
- Price
- CVAC $5.35
- DCOM $30.42
- Analyst Decision
- CVAC Hold
- DCOM Strong Buy
- Analyst Count
- CVAC 3
- DCOM 3
- Target Price
- CVAC $6.83
- DCOM $36.50
- AVG Volume (30 Days)
- CVAC 471.1K
- DCOM 166.0K
- Earning Date
- CVAC 11-11-2025
- DCOM 10-21-2025
- Dividend Yield
- CVAC N/A
- DCOM 3.29%
- EPS Growth
- CVAC N/A
- DCOM N/A
- EPS
- CVAC 1.01
- DCOM 0.87
- Revenue
- CVAC $599,540,810.00
- DCOM $314,165,000.00
- Revenue This Year
- CVAC N/A
- DCOM $49.66
- Revenue Next Year
- CVAC $23.95
- DCOM $16.29
- P/E Ratio
- CVAC $5.32
- DCOM $34.78
- Revenue Growth
- CVAC 675.15
- DCOM N/A
- 52 Week Low
- CVAC $2.37
- DCOM $23.25
- 52 Week High
- CVAC $5.72
- DCOM $37.60
- Technical
- Relative Strength Index (RSI)
- CVAC 44.43
- DCOM 55.09
- Support Level
- CVAC $5.32
- DCOM $30.18
- Resistance Level
- CVAC $5.41
- DCOM $31.11
- Average True Range (ATR)
- CVAC 0.04
- DCOM 0.65
- MACD
- CVAC -0.01
- DCOM -0.07
- Stochastic Oscillator
- CVAC 33.33
- DCOM 24.79
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.